LAB · Standard Biotools Inc.
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
| Program Announced | Authorized | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2024-02-06 | $50,000,000 | $9,500,000 | 2026-08-05 | 2026-03-01 expired | 10-Q , filed 2026-08-05 |
Cash spent on buybacks by quarter
Cash deployed each quarter, with the average price paid where the company reported it. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2025-12-31 | $0 | 10-K, filed 2026-03-16 |
| 2024-12-31 | $40,490,000 | 10-K, filed 2026-03-16 |
| 2023-12-31 | $5,414,000 | 10-K, filed 2026-03-16 |
| 2022-12-31 | $563,000 | 10-K, filed 2025-03-11 |
| 2021-12-31 | $0 | 10-K, filed 2023-03-14 |